Daskalopoulou Marina, Rodger Alison J, Phillips Andrew N, Sherr Lorraine, Elford Jonathan, McDonnell Jeffrey, Edwards Simon, Perry Nicky, Wilkins Ed, Collins Simon, Johnson Anne M, Burman William J, Speakman Andrew, Lampe Fiona C
Research Department of Infection and Population Health, University College London, London, UK.
City University London, London, UK.
Sex Transm Infect. 2017 Dec;93(8):590-598. doi: 10.1136/sextrans-2016-053029. Epub 2017 Jul 5.
HIV transmission is ongoing among men who have sex with men (MSM) in the UK. Sex without a condom (condomless sex, CLS) is the main risk factor. We investigated the prevalence of and factors associated with types of CLS.
Cross-sectional questionnaire study in UK HIV clinics in 2011/2012 (ASTRA). MSM diagnosed with HIV for ≥3 months reported on anal and vaginal sex, CLS with HIV-serodifferent partners (CLS-D) and CLS with HIV-seroconcordant (CLS-C) partners in the previous 3 months. Mutually exclusive sexual behaviours were as follows: (1) Higher HIV risk CLS-D (not on antiretroviral therapy (ART) or clinic-recorded viral load(VL) >50 c/mL), (2) Other CLS-D, (3) CLS-C without CLS-D, (4) Condom-protected sex only and (5) No anal or vaginal sex. Associations were examined of sociodemographic, HIV-related, lifestyle, and other sexual measures with the five categories of sexual behaviour. We examined the prevalence of higher HIV risk CLS-D incorporating (in addition to ART and VL) time on ART, ART non-adherence, and recent sexually transmitted infections (STIs).
Among 2189 HIV-diagnosed MSM (87% on ART), prevalence of any CLS in the past 3 months was 38.2% (95% CI 36.2% to 40.4%) and that of any CLS-D was 16.3% (14.8%-17.9%). The five-category classification was as follows: (1) Higher HIV risk CLS-D: 4.2% (3.5% to 5.2%), (2) Other CLS-D: 12.1% (10.8% to 13.5%), (3) CLS-C without CLS-D: 21.9% (20.2% to 23.7%), (4) Condom-protected sex only: 25.4% (23.6% to 27.3%) and (5) No anal or vaginal sex: 36.4% (34.3% to 38.4%). Compared with men who reported condom-protected sex only, MSM who reported any CLS in the past 3 months had higher prevalence of STIs, chemsex-associated drug use, group sex, higher partner numbers, and lifetime hepatitis C. Prevalence of higher HIV risk CLS-D ranged from 4.2% to 7.5% according to criteria included.
CLS was prevalent among HIV-diagnosed MSM, but CLS-D with higher HIV transmission risk was overall low. CLS-D is no longer the most appropriate measure of HIV transmission risk behaviour among people with diagnosed HIV; accounting for VL is important.
在英国,男男性行为者(MSM)中存在持续的HIV传播。无保护性行为(无套性行为,CLS)是主要风险因素。我们调查了CLS类型的患病率及其相关因素。
2011/2012年在英国HIV诊所进行的横断面问卷调查研究(ASTRA)。确诊感染HIV≥3个月的MSM报告了前3个月的肛交和阴道性交情况、与HIV血清学不同伴侣的无套性行为(CLS-D)以及与HIV血清学一致伴侣的无套性行为(CLS-C)。相互排斥的性行为如下:(1)HIV高风险CLS-D(未接受抗逆转录病毒治疗(ART)或临床记录的病毒载量(VL)>50拷贝/mL),(2)其他CLS-D,(3)无CLS-D的CLS-C,(4)仅采取有保护措施的性行为,(5)无肛交或阴道性交。研究了社会人口学、HIV相关、生活方式及其他性方面的指标与这五类性行为之间的关联。我们还调查了纳入ART治疗时间、ART治疗依从性及近期性传播感染(STI)情况后(除ART和VL外)HIV高风险CLS-D的患病率。
在2189例确诊感染HIV的MSM中(87%接受ART治疗),过去3个月内任何CLS的患病率为38.2%(95%CI 36.2%至40.4%),任何CLS-D的患病率为16.3%(14.8%-17.9%)。五类分类情况如下:(1)HIV高风险CLS-D:4.2%(3.5%至5.2%),(2)其他CLS-D:12.1%(10.8%至13.5%),(3)无CLS-D的CLS-C:21.9%(20.2%至23.7%),(4)仅采取有保护措施的性行为:25.4%(23.6%至27.3%),(5)无肛交或阴道性交:36.4%(34.3%至38.4%)。与仅报告采取有保护措施性行为的男性相比,过去3个月内报告有任何CLS的MSM患STI、与化学性行为相关的药物使用、群交、性伴侣数量更多以及有丙型肝炎病史的患病率更高。根据纳入标准,HIV高风险CLS-D的患病率在4.2%至7.5%之间。
CLS在确诊感染HIV的MSM中普遍存在,但具有较高HIV传播风险的CLS-D总体较低。CLS-D已不再是确诊感染HIV者中HIV传播风险行为的最恰当衡量指标;考虑病毒载量很重要。